FARMINGTON, N.M., June 2, 2026 /PRNewswire/ -- Navajo Transitional Energy Company, LLC (NTEC) today announced the addition of nine new home solar installations under...
Guideline aids healthcare, food, retail, and apparel companies standardize packaging data to support regulatory reporting and sustainability EWING, N.J., June 2, 2026 /PRNewswire/ --...
ISS National Lab highlights space R&D and growing low Earth orbit economy at ASCEND 2026KENNEDY SPACE CENTER, Fla., June 2, 2026 /PRNewswire/ -- The International...
DELRAY BEACH, Fla., June 2, 2026 /PRNewswire/ -- According to MarketsandMarkets, "Recycled Plastics Market by Source (Bottles, Fibers, Films, Foams), Process, Plastic Type (PET, PP,...
Lantra warns that a severe UK land-based skills shortage threatens the £41bn sector and food security, urging immediate Government action to close the gap.
SINGAPORE, June 2, 2026 /PRNewswire/ -- Aippy, the world's first AI-native game community developed by NADA AI, today announced that it has raised tens of...
Industry veterans join as MemryX expands its production-proven AI architecture from edge deployments into the data centerANN ARBOR, Mich., June 2, 2026 /PRNewswire/ --...
Tokyo, Japan and Cambridge, UK, 2 June 2026 – Nxera Pharma Co., Ltd. (“Nxera” or the “Company”) announces that the Ministry of Food and Drug Safety (MFDS) of the Republic of Korea has granted Orphan Drug Designation (ODD) and Global Innovative Products on Fast Track (GIFT) designation to vamorolone for the treatment of Duchenne muscular dystrophy (DMD). The Company plans to submit a Marketing Authorization Application (MAA) for vamorolone in South Korea during 2026.
With more than $1B in secured business, the funding accelerates inventory build-out to meet the rising demand for open, multi-vendor, and Heterogeneous AI infrastructure...
With more than $1B in secured business, the funding accelerates inventory build-out to meet the rising demand for open, multi-vendor, and Heterogeneous AI infrastructure...
With more than $1B in secured business, the funding accelerates inventory build-out to meet the rising demand for open, multi-vendor, and Heterogeneous AI infrastructure...